PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Recommendation of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus-Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak.

Abstract A substantial increase in the number of mumps outbreaks and outbreak-associated cases has occurred in the United States since late 2015 (1,2). To address this public health problem, the Advisory Committee on Immunization Practices (ACIP) reviewed the available evidence and determined that a third dose of measles, mumps, rubella (MMR) vaccine is safe and effective at preventing mumps. During its October 2017 meeting, ACIP recommended a third dose of a mumps virus-containing vaccine* for persons previously vaccinated with 2 doses who are identified by public health authorities as being part of a group or population at increased risk for acquiring mumps because of an outbreak. The purpose of the recommendation is to improve protection of persons in outbreak settings against mumps disease and mumps-related complications. This recommendation supplements the existing ACIP recommendations for mumps vaccination (3).
PMID
Related Publications

Notice to readers: updated recommendations of the Advisory Committee on Immunization Practices (ACIP) for the control and elimination of mumps.

Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Mumps Outbreak at a University and Recommendation for a Third Dose of Measles-Mumps-Rubella Vaccine - Illinois, 2015-2016.

Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors

Mayor MeshTerms

Immunization Schedule

Practice Guidelines as Topic

Keywords
Journal Title mmwr. morbidity and mortality weekly report
Publication Year Start




PMID- 29324728
OWN - NLM
STAT- MEDLINE
DCOM- 20180112
LR  - 20180112
IS  - 1545-861X (Electronic)
IS  - 0149-2195 (Linking)
VI  - 67
IP  - 1
DP  - 2018 Jan 12
TI  - Recommendation of the Advisory Committee on Immunization Practices for Use of a
      Third Dose of Mumps Virus-Containing Vaccine in Persons at Increased Risk for
      Mumps During an Outbreak.
PG  - 33-38
LID - 10.15585/mmwr.mm6701a7 [doi]
AB  - A substantial increase in the number of mumps outbreaks and outbreak-associated
      cases has occurred in the United States since late 2015 (1,2). To address this
      public health problem, the Advisory Committee on Immunization Practices (ACIP)
      reviewed the available evidence and determined that a third dose of measles,
      mumps, rubella (MMR) vaccine is safe and effective at preventing mumps. During
      its October 2017 meeting, ACIP recommended a third dose of a mumps
      virus-containing vaccine* for persons previously vaccinated with 2 doses who are 
      identified by public health authorities as being part of a group or population at
      increased risk for acquiring mumps because of an outbreak. The purpose of the
      recommendation is to improve protection of persons in outbreak settings against
      mumps disease and mumps-related complications. This recommendation supplements
      the existing ACIP recommendations for mumps vaccination (3).
FAU - Marin, Mona
AU  - Marin M
FAU - Marlow, Mariel
AU  - Marlow M
FAU - Moore, Kelly L
AU  - Moore KL
FAU - Patel, Manisha
AU  - Patel M
LA  - eng
PT  - Journal Article
DEP - 20180112
PL  - United States
TA  - MMWR Morb Mortal Wkly Rep
JT  - MMWR. Morbidity and mortality weekly report
JID - 7802429
RN  - 0 (Mumps Vaccine)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Advisory Committees
MH  - Centers for Disease Control and Prevention (U.S.)
MH  - Child
MH  - Child, Preschool
MH  - Disease Outbreaks/*prevention & control
MH  - Humans
MH  - *Immunization Schedule
MH  - Infant
MH  - Mumps/epidemiology/*prevention & control
MH  - Mumps Vaccine/*administration & dosage
MH  - *Practice Guidelines as Topic
MH  - Risk Assessment
MH  - United States/epidemiology
MH  - Young Adult
COIS- No conflicts of interest were reported.
EDAT- 2018/01/13 06:00
MHDA- 2018/01/13 06:01
CRDT- 2018/01/12 06:00
PHST- 2018/01/12 06:00 [entrez]
PHST- 2018/01/13 06:00 [pubmed]
PHST- 2018/01/13 06:01 [medline]
AID - 10.15585/mmwr.mm6701a7 [doi]
PST - epublish
SO  - MMWR Morb Mortal Wkly Rep. 2018 Jan 12;67(1):33-38. doi: 10.15585/mmwr.mm6701a7.